Pacific Edge plans to open its first US franchise to market the company’s bladder cancer detection test, Cxbladder, to urologists in the United States by the end of the year.
The Dunedin-based firm will set up shop at the Hershey Center for Applied Research (HCAR) on America’s East Coast.
The 11,348 square-foot Pacific Edge facility will serve as an office and processing facility for the analysis of the Cxbladder test – which utilises the expression of genes in the patients’ urine to detect the presence of bladder cancer accurately and non-invasively.
Planning and construction for the new facility is currently underway and will involve about 100 new employees over the next three year.
“It’s a huge opportunity to be in the US market,” says David Darling, CEO of Pacific Edge, “It’s probably the biggest prize in the world when it comes to a responsive healthcare market that really understands what molecular diagnostics can do in a clinical setting.”
Pacific Edge has been scoping potential marketing opportunities for some time.
“As part of our business development process we met the people from HCAR in Europe at a business partnering forum, where we were looking for opportunities and various reasons in the United States to see where we should be best located strategically,” Mr Darling says.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Shareholders approve completing $400m Central Plains irrigation scheme in 2018
- Marlborough displaces Central Otago for best Pinot Noir in world competition
- Court rules against Chinese investor over $7.3m Auckland property deal
- EQC boss Ian Simpson to leave at the end of the year to head up GNS
- READER POLL RESULT: Who won the first presidential debate?
Most listened to
- Ironically, Trump showed the lack of stamina he had accused Clinton of, says NBR's Rob Hosking
- NZX market surveillance manager Fraser Wyeth gives evidence at the Warminger trial
- Hellaby shareholder Aaron Bhatnagar says why he thinks Bapcor's offer is too low
- No knockout blows in first presidential debate, says NBR's Nevil Gibson
- Intueri's problems raise questions for the board, says Martin Watson of the Shareholders Association